These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9086573)

  • 1. Conversion of non-iodine-concentrating differentiated thyroid carcinoma metastases into iodine-concentrating foci after anticancer chemotherapy.
    Morris JC; Kim CK; Padilla ML; Mechanick JI
    Thyroid; 1997 Feb; 7(1):63-6. PubMed ID: 9086573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
    Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
    J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
    Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
    J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
    J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
    Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
    Travagli JP; Cailleux AF; Ricard M; Baudin E; Caillou B; Parmentier C; Schlumberger M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2675-80. PubMed ID: 9709930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian endometriosis cyst with iodine 131 uptake : first case of false positive in the follow up for differentiated thyroid carcinoma].
    Lungo M; Tenenbaum F; Chaumerliac P; Vons C; Mirat A; Beuzen F; Luton JP; Richard B
    Ann Endocrinol (Paris); 2000 May; 61(2):147-50. PubMed ID: 10891665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Marcuse HR; de Vijlder JJ
    J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervicomediastinal magnetic resonance imaging in persistent or recurrent papillary thyroid carcinoma: clinical use and limits.
    Toubert ME; Cyna-Gorse F; Zagdanski AM; Noel-Wekstein S; Cattan P; Billotey C; Sarfati E; Rain JD
    Thyroid; 1999 Jun; 9(6):591-7. PubMed ID: 10411122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
    Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
    J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor redifferentiation in papillary thyroid carcinoma alter retinoic acid administration].
    Camacho Martí V; Estorch Cabrera M; Mena González E; Fuertes Manuel J; Hernández Fructuoso MA; Flotats Giralt A; Carrió Gasset I
    Rev Esp Med Nucl; 2004; 23(3):193-6. PubMed ID: 15153363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
    Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
    J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper retropharyngeal node involvement in differentiated thyroid carcinoma demonstrated by 131I scintigraphy.
    Leger AF; Baillet G; Dagousset F; Vincenot MI; Izembart M; Clerc J; Barritault L
    Br J Radiol; 2000 Dec; 73(876):1260-4. PubMed ID: 11205668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
    Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
    Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
    Moser E; Fritsch S; Braun S
    Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
    Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG
    J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.